We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

QIAGEN Acquires ESE GmbH

News   Jan 13, 2010

 
QIAGEN Acquires ESE GmbH
 
 
 

RELATED ARTICLES

Post-heart Attack Antibody Levels May Guide Treatment

News

Levels of antiphospholipid antibodies, which are associated with rheumatic diseases, are also elevated in myocardial infarction without any autoimmune co-morbidity.

READ MORE

Ancient Enzymes the Catalysts for Discoveries

News

University of Queensland-led research recreating 450 million-year-old enzymes has resulted in a biochemical engineering ‘hack’ which could lead to new drugs, flavours, fragrances and biofuels.

READ MORE

Cellular Dumpster-diving Enables Degradation Landscape Exploration

News

A novel technology for profiling protein turnover and degradation offers new insight into diagnosis and understanding the molecular basis of autoimmunity, cancer, neurodegeneration and other disorders.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE